Navidea Biopharmaceutica (Israel) Performance

NAVB -- Israel Stock  

ILS 73.10  4.90  6.28%

Macroaxis gives Navidea Biopharmaceutica performance score of 0 on a scale of 0 to 100. The company secures Beta (Market Risk) of 1.427 which conveys that as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Navidea Biopharmaceutica will likely underperform.. Even though it is essential to pay attention to Navidea Biopharmaceutica price patterns, it is always good to be careful when utilizing equity historical price patterns. Macroaxis philosophy towards estimating future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Navidea Biopharmaceutica exposes twenty-one different technical indicators which can help you to evaluate its performance. Navidea Biopharmaceutica has expected return of -4.658%. Please be advised to verify Navidea Biopharmaceuticals Treynor Ratio, Value At Risk, Downside Variance, as well as the relationship between Maximum Drawdown and Potential Upside to decide if Navidea Biopharmaceutica past performance will be repeated at some point in the near future.
Horizon     30 Days    Login   to change

Navidea Biopharmaceutica Relative Risk vs. Return Landscape

If you would invest  9,800  in Navidea Biopharmaceuticals on November 17, 2018 and sell it today you would lose (2,490)  from holding Navidea Biopharmaceuticals or give up 25.41% of portfolio value over 30 days. Navidea Biopharmaceuticals is generating negative expected returns and assumes 4.9924% volatility on return distribution over the 30 days horizon. Simply put, 45% of equities are less volatile than Navidea Biopharmaceuticals and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 
Assuming 30 trading days horizon, Navidea Biopharmaceuticals is expected to under-perform the market. In addition to that, the company is 3.89 times more volatile than its market benchmark. It trades about -0.93 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.1 per unit of volatility.

Navidea Biopharmaceutica Market Risk Analysis

Sharpe Ratio = -0.933
Good Returns
Average Returns
Small Returns
Negative ReturnsNAVB

Navidea Biopharmaceutica Relative Performance Indicators

Estimated Market Risk
  actual daily
 45 %
of total potential
Expected Return
  actual daily
 0 %
of total potential
Risk-Adjusted Return
  actual daily
 0 %
of total potential
Based on monthly moving average Navidea Biopharmaceutica is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Navidea Biopharmaceutica by adding it to a well-diversified portfolio.

Navidea Biopharmaceutica Performance Rating

Navidea Biopharmaceuticals Risk Adjusted Performance Analysis


Risk-Adjusted Performance

Over the last 30 days Navidea Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions.

Navidea Biopharmaceutica Alerts

Equity Alerts and Improvement Suggestions

Navidea Biopharmaceutica is not yet fully synchronised with the market data
Navidea Biopharmaceutica generates negative expected return over the last 30 days
Navidea Biopharmaceutica has high historical volatility and very poor performance
Navidea Biopharmaceutica has accumulated S2.2 Million in debt which can lead to volatile earnings
The company reported revenue of 1.44M. Net Loss for the year was (16.88M) with profit before overhead, payroll, taxes, and interest of 1.81M.

Navidea Biopharmaceutica Performance Indicators

Navidea Biopharmaceutica Basic Price Performance Measures

Quick Ratio1.27
Fifty Two Week Low82.60
Fifty Two Week High88.60
Please see also Stocks Correlation. Please also try CEO Directory module to screen ceos from public companies around the world.